[go: up one dir, main page]

RU2010146997A - PHARMACEUTICAL COMPOSITION CONTAINING SILDENAFIL AND / OR ALPROSTADIL, MINOXIDIL AND / OR EUFILLIN, TESTOSTERON AND / OR YOCHIMBIN AND LIPOSOMES FOR LOCAL USE - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING SILDENAFIL AND / OR ALPROSTADIL, MINOXIDIL AND / OR EUFILLIN, TESTOSTERON AND / OR YOCHIMBIN AND LIPOSOMES FOR LOCAL USE Download PDF

Info

Publication number
RU2010146997A
RU2010146997A RU2010146997/15A RU2010146997A RU2010146997A RU 2010146997 A RU2010146997 A RU 2010146997A RU 2010146997/15 A RU2010146997/15 A RU 2010146997/15A RU 2010146997 A RU2010146997 A RU 2010146997A RU 2010146997 A RU2010146997 A RU 2010146997A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
minoxidil
liposomes
yohimbine
sildenafil
Prior art date
Application number
RU2010146997/15A
Other languages
Russian (ru)
Other versions
RU2482847C2 (en
Inventor
Леонид Леонидович Клопотенко (RU)
Леонид Леонидович Клопотенко
Original Assignee
Леонид Леонидович Клопотенко (RU)
Леонид Леонидович Клопотенко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Леонид Леонидович Клопотенко (RU), Леонид Леонидович Клопотенко filed Critical Леонид Леонидович Клопотенко (RU)
Priority to RU2010146997/15A priority Critical patent/RU2482847C2/en
Publication of RU2010146997A publication Critical patent/RU2010146997A/en
Application granted granted Critical
Publication of RU2482847C2 publication Critical patent/RU2482847C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Фармацевтическая композиция для местного применения, содержащая силденафил, миноксидил, тестостерон и фармацевтически приемлемые носители или эксципиенты, отличающаяся тем, что она дополнительно включает в себя липосомы. ! 2. Фармацевтическая композиция по п.1, отличающаяся тем, что она вместо силденафила содержит алпростадил, миноксидила - эуфиллин, тестостерона - йохимбин. ! 3. Фармацевтическая композиция по п.2, отличающаяся тем, что она имеет следующий состав, мас.%: ! Алростадил 0,01-5,0 Эуфиллин 0,01-5,0 Липосомы 0,01-20,0 Йохимбин 0,01-5,0 Эмульгатор 0,5-10,0 Консервант 0,05-1,0 Вода деминерализованная 64,0-99,41 ! 4. Фармацевтическая композиция по п.1, отличающаяся тем, что она вместо тестостерона содержит йохимбин. ! 5. Фармацевтическая композиция по п.1, отличающаяся тем, что она имеет следующий состав, мас.%: ! Силденафил 0,01-5,0 Миноксидил 0,01-5,0 Липосомы 0,01-20,0 Йохимбин 0,01-5,0 Эмульгатор 0,5-10,0 Консервант 0,05-1,0 Вода деминерализованная 64,0-99,41 1. A topical pharmaceutical composition comprising sildenafil, minoxidil, testosterone and pharmaceutically acceptable carriers or excipients, characterized in that it further includes liposomes. ! 2. The pharmaceutical composition according to claim 1, characterized in that instead of sildenafil it contains alprostadil, minoxidil - aminophylline, testosterone - yohimbine. ! 3. The pharmaceutical composition according to claim 2, characterized in that it has the following composition, wt.%:! Alrostadil 0.01-5.0 Eufillin 0.01-5.0 Liposomes 0.01-20.0 Yohimbine 0.01-5.0 Emulsifier 0.5-10.0 Preservative 0.05-1.0 Demineralized water 64.0-99.41! 4. The pharmaceutical composition according to claim 1, characterized in that instead of testosterone it contains yohimbine. ! 5. The pharmaceutical composition according to claim 1, characterized in that it has the following composition, wt.%:! Sildenafil 0.01-5.0 Minoxidil 0.01-5.0 Liposomes 0.01-20.0 Yohimbine 0.01-5.0 Emulsifier 0.5-10.0 Preservative 0.05-1.0 Demineralized water 64.0-99.41

Claims (5)

1. Фармацевтическая композиция для местного применения, содержащая силденафил, миноксидил, тестостерон и фармацевтически приемлемые носители или эксципиенты, отличающаяся тем, что она дополнительно включает в себя липосомы.1. A topical pharmaceutical composition comprising sildenafil, minoxidil, testosterone and pharmaceutically acceptable carriers or excipients, characterized in that it further includes liposomes. 2. Фармацевтическая композиция по п.1, отличающаяся тем, что она вместо силденафила содержит алпростадил, миноксидила - эуфиллин, тестостерона - йохимбин.2. The pharmaceutical composition according to claim 1, characterized in that instead of sildenafil it contains alprostadil, minoxidil - aminophylline, testosterone - yohimbine. 3. Фармацевтическая композиция по п.2, отличающаяся тем, что она имеет следующий состав, мас.%:3. The pharmaceutical composition according to claim 2, characterized in that it has the following composition, wt.%: АлростадилAlrostadil 0,01-5,00.01-5.0 ЭуфиллинEufillin 0,01-5,00.01-5.0 ЛипосомыLiposomes 0,01-20,00.01-20.0 ЙохимбинYohimbine 0,01-5,00.01-5.0 ЭмульгаторEmulsifier 0,5-10,00.5-10.0 КонсервантPreservative 0,05-1,00.05-1.0 Вода деминерализованнаяDemineralized water 64,0-99,4164.0-99.41
4. Фармацевтическая композиция по п.1, отличающаяся тем, что она вместо тестостерона содержит йохимбин.4. The pharmaceutical composition according to claim 1, characterized in that instead of testosterone it contains yohimbine. 5. Фармацевтическая композиция по п.1, отличающаяся тем, что она имеет следующий состав, мас.%:5. The pharmaceutical composition according to claim 1, characterized in that it has the following composition, wt.%: СилденафилSildenafil 0,01-5,00.01-5.0 МиноксидилMinoxidil 0,01-5,00.01-5.0 ЛипосомыLiposomes 0,01-20,00.01-20.0 ЙохимбинYohimbine 0,01-5,00.01-5.0 ЭмульгаторEmulsifier 0,5-10,00.5-10.0 КонсервантPreservative 0,05-1,00.05-1.0 Вода деминерализованнаяDemineralized water 64,0-99,4164.0-99.41
RU2010146997/15A 2010-11-17 2010-11-17 Pharmaceutical composition, containing sildenafil or alprostadil, minoxidil or euphyllin, testosteron or yohimbine and liposomes for local application RU2482847C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2010146997/15A RU2482847C2 (en) 2010-11-17 2010-11-17 Pharmaceutical composition, containing sildenafil or alprostadil, minoxidil or euphyllin, testosteron or yohimbine and liposomes for local application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010146997/15A RU2482847C2 (en) 2010-11-17 2010-11-17 Pharmaceutical composition, containing sildenafil or alprostadil, minoxidil or euphyllin, testosteron or yohimbine and liposomes for local application

Publications (2)

Publication Number Publication Date
RU2010146997A true RU2010146997A (en) 2012-05-27
RU2482847C2 RU2482847C2 (en) 2013-05-27

Family

ID=46231311

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010146997/15A RU2482847C2 (en) 2010-11-17 2010-11-17 Pharmaceutical composition, containing sildenafil or alprostadil, minoxidil or euphyllin, testosteron or yohimbine and liposomes for local application

Country Status (1)

Country Link
RU (1) RU2482847C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114425052A (en) * 2020-10-29 2022-05-03 新光医疗财团法人新光吴火狮纪念医院 Sildenafil is used to prepare pharmaceutical composition and use for treating ischemia

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80393C2 (en) * 2000-12-07 2007-09-25 Алтана Фарма Аг Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
KR101289917B1 (en) * 2004-10-18 2013-07-25 폴리문 사이언티픽 임무노이비오로기쉐 포르슝 게엠베하 Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and therapeutically use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114425052A (en) * 2020-10-29 2022-05-03 新光医疗财团法人新光吴火狮纪念医院 Sildenafil is used to prepare pharmaceutical composition and use for treating ischemia
CN114425052B (en) * 2020-10-29 2024-03-22 新光医疗财团法人新光吴火狮纪念医院 Sildenafil for preparing pharmaceutical composition for treating ischemia and application thereof

Also Published As

Publication number Publication date
RU2482847C2 (en) 2013-05-27

Similar Documents

Publication Publication Date Title
RU2010146997A (en) PHARMACEUTICAL COMPOSITION CONTAINING SILDENAFIL AND / OR ALPROSTADIL, MINOXIDIL AND / OR EUFILLIN, TESTOSTERON AND / OR YOCHIMBIN AND LIPOSOMES FOR LOCAL USE
RU2011124636A (en) LIQUID-SUSTER FOR HYDRAULIC GROUND RIP
RU2011110649A (en) SAMARI-CONTAINING SPIN-GLASS MAGNETIC MATERIAL
RU2010151556A (en) PHARMACEUTICAL COMPOSITION CONTAINING ENZYMES: LYSOZIM, PEROXIDASE, POVIARGOL AND LIPOSOMES, FOR LOCAL USE
RU2011115176A (en) REFRIGERATOR
RU2009122296A (en) IMMUNOMETABOLIC ANTHELMINTIC DRUG
RU2010146999A (en) PHARMACEUTICAL COMPOSITION CONTAINING CHONDROITIN SULPHATE AND / OR HYALURONIDASE AND LIPOSOMES FOR LOCAL USE
RU2010146994A (en) Pharmaceutical composition containing fluconazole and / or ketoconazole and / or terbinafine and liposomes for topical application
RU2012124134A (en) DISINFECTANT
RU2011140993A (en) INSECTICIDAL COMPOSITION
RU2011100571A (en) PHARMACEUTICAL COMPOSITION CONTAINING CHONDROITIN SULPHATE AND / OR HYALURONIDASE AND LIPOSOMES FOR LOCAL USE
RU2012142402A (en) COMPOSITION FOR SUSPENSING A GAS WELL LOCATED IN PERMANENT FROZEN HIGH-SOLD ROCKS
RU2011100289A (en) COSMETIC COMPOSITION CONTAINING ACETYLHEXAPEPTID-6 AND LIPOSOMES FOR LOCAL USE
RU2012116371A (en) WELL KILLING LIQUID
RU2011114965A (en) PHARMACEUTICAL COMPOSITION CONTAINING INSULIN AND LIPOSOMES FOR LOCAL APPLICATION AS A BIOFILM
RU2013118038A (en) COMPOSITION BASED ON DIHYDROQUERCERETINE INCLUDED IN PHOSPHOLIPID NANOPARTICLES
RU2010126054A (en) COSMETIC COMPOSITION CONTAINING CHONDROITIN SULPHATE AND / OR HYALURONIDASE AND LIPOSOMES FOR LOCAL USE
RU2012134674A (en) BIOLOGICALLY ACTIVE COMPOSITION
RU2011100291A (en) SUBLINGUAL OINTMENT CONTAINING INSULIN AND LIPOSOMES
RU2011100552A (en) RECTAL OINTMENT CONTAINING INSULIN AND LIPOSOMES
RU2015114205A (en) Photosensitizer gel for photodynamic therapy
RU2012128102A (en) PHARMACEUTICAL COMPOSITION CONTAINING EPIRUBICIN OR MITOXANTRON OR OR MITOMYCIN AND LIPOSOMA OR BETA-CYCLODEXTRIN
RU2012100471A (en) MEDICAL AND COSMETIC PRODUCT
RU2013112463A (en) FLOCULANT BASED ON POLYACRYLAMIDE
RU2012105183A (en) PHARMACEUTICAL COMPOSITION FOR PREVENTION OF THE MITOMYCIN-O PROLIFERATIVE CELL REACTION

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20161118